Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752350			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004116		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752351			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005466		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752352			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120417	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752353			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004613		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689463			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004581		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689464			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005535		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689465			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005529		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120418	Homo sapiens	Other	part african and irish	Not Hispanic or Latino		Male	Age at enrollment		83	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689466			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004820		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752355			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005679		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752356			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005393		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752357			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005136		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120419	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		75	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752358			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005553		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689467			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004055		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689468			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003929		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689469			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004149		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120420	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689470			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004175		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689471			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004837		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689472			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005411		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689473			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005332		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120421	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689474			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004307		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689475			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004479		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689476			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005373		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689477			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003784		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120422	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689478			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005072		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752359			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004932		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752360			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005690		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752361			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120423	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752362			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005653		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689479			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005058		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689480			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004564		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689481			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004654		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120424	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689482			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004397		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689483			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005111		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689484			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005036		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689485			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003939		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120425	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689486			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005150		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752363			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003694		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752364			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004043		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752365			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004114		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120426	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752366			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005067		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689487			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004457		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689488			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004533		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689489			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003981		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120427	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		69	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689490			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005347		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689491			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003827		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689492			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003736		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689493			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003656		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120428	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689494			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005434		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752367			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004451		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752368			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005582		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752369			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005515		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804538	Flow cytometry workspace	Panel_L1_Run_1.804538.wsp	Panel_L1_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804546	Flow cytometry workspace	Panel_P2_Run_1-regated.804546.wsp	Panel_P2_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804545	Flow cytometry workspace	Panel_P13_Run_1-regated.804545.wsp	Panel_P13_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804544	Flow cytometry workspace	Panel_P9-P10_Run_1.804544.wsp	Panel_P9-P10_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804543	Flow cytometry workspace	Panel P1.804543.wsp	Panel P1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804542	Flow cytometry workspace	Yr2 Run 1 Panel L5.804542.wsp	Yr2 Run 1 Panel L5.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804541	Flow cytometry workspace	Panel_L4_Run_1-regated.804541.wsp	Panel_L4_Run_1-regated.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804540	Flow cytometry workspace	Panel_L3_Run_1.804540.wsp	Panel_L3_Run_1.wsp
SUB120429	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752370			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005123		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804539	Flow cytometry workspace	Panel_L2_Run_1-regated.804539.wsp	Panel_L2_Run_1-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689495			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004355		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689496			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004012		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689497			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120430	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689498			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004944		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752371			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005019		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752372			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005194		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804556	Flow cytometry workspace	Panel_L1_Run_2.804556.wsp	Panel_L1_Run_2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804564	Flow cytometry workspace	Panel P2 Run 2.804564.wsp	Panel P2 Run 2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804563	Flow cytometry workspace	Panel_P13_Run_2-regated.804563.wsp	Panel_P13_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804562	Flow cytometry workspace	Panel_P9-P10_Run_2-regated.804562.wsp	Panel_P9-P10_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804561	Flow cytometry workspace	Panel P1 Run 2.804561.wsp	Panel P1 Run 2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804560	Flow cytometry workspace	Yr2 Run 2 Panel L5.804560.wsp	Yr2 Run 2 Panel L5.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804559	Flow cytometry workspace	Panel_L4_Run_2-regated.804559.wsp	Panel_L4_Run_2-regated.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804558	Flow cytometry workspace	Panel_L3_Run_2.804558.wsp	Panel_L3_Run_2.wsp
SUB120432	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752373			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004226		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804557	Flow cytometry workspace	Panel_L2_Run_2-regated.804557.wsp	Panel_L2_Run_2-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752374			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005550		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752375			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005688		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120433	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752376			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005004		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689499			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689500			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004595		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689501			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120435	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		70	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689502			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003958		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689503			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004155		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689504			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004049		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689505			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004655		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804565	Flow cytometry workspace	Panel_L1_Run_3.804565.wsp	Panel_L1_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804573	Flow cytometry workspace	Panel_P2_Run_3-regated.804573.wsp	Panel_P2_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804572	Flow cytometry workspace	Panel_P13_Run_3-regated.804572.wsp	Panel_P13_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804571	Flow cytometry workspace	Panel_P9-P10_Run_3-regated.804571.wsp	Panel_P9-P10_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804570	Flow cytometry workspace	Panel P1 Run 3.804570.wsp	Panel P1 Run 3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804569	Flow cytometry workspace	Yr2 Run 3 Panel L5.804569.wsp	Yr2 Run 3 Panel L5.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804568	Flow cytometry workspace	Panel_L4_Run_3-regated.804568.wsp	Panel_L4_Run_3-regated.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804567	Flow cytometry workspace	Panel_L3_Run_3.804567.wsp	Panel_L3_Run_3.wsp
SUB120436	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689506			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005174		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804566	Flow cytometry workspace	Panel_L2_Run_3-regated.804566.wsp	Panel_L2_Run_3-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689507			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689508			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003998		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689509			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003663		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120437	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		76	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689510			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004238		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689511			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004436		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689512			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005110		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689513			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003913		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120440	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		81	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689514			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003720		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689515			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004445		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689516			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004758		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689517			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120441	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		77	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689518			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004790		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689519			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003931		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689520			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005319		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689521			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120442	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		72	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689522			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004978		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689523			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004817		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689524			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004235		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689525			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004541		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120445	Homo sapiens	Unknown		Not Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689526			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689527			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004960		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689528			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004080		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689529			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004567		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120446	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689530			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003856		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752378			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005139		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752379			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003751		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804574	Flow cytometry workspace	Panel_L1_Run_4.804574.wsp	Panel_L1_Run_4.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804582	Flow cytometry workspace	Panel_P2_Run_4-regated.804582.wsp	Panel_P2_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804581	Flow cytometry workspace	Panel_P13_Run_4-regated.804581.wsp	Panel_P13_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804580	Flow cytometry workspace	Panel_P9-P10_Run_4-regated.804580.wsp	Panel_P9-P10_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804579	Flow cytometry workspace	Panel P1 Run 4b.804579.wsp	Panel P1 Run 4b.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804578	Flow cytometry workspace	Yr2 Run 4 Panel L5.804578.wsp	Yr2 Run 4 Panel L5.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804577	Flow cytometry workspace	Panel_L4_Run_4-regated.804577.wsp	Panel_L4_Run_4-regated.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804576	Flow cytometry workspace	Panel_L3_Run_4.804576.wsp	Panel_L3_Run_4.wsp
SUB120449	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752380			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004258		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804575	Flow cytometry workspace	Panel_L2_Run_4-regated.804575.wsp	Panel_L2_Run_4-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689531			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004519		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689532			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004299		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689533			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004259		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120450	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689534			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004414		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752383			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005577		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752385			PBMC		3	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003641		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120451	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752386			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005540		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689535			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003845		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689536			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004873		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689537			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003826		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120452	Homo sapiens	Other	hispanic/african american	Hispanic or Latino		Female	Age at enrollment		28	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689538			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689539			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004571		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689540			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005552		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689541			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004446		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120457	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689542			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005248		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689543			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004734		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689544			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003946		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689545			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005672		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804583	Flow cytometry workspace	Panel_L1_Run_5.804583.wsp	Panel_L1_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804591	Flow cytometry workspace	Panel_P2_Run_5-regated.804591.wsp	Panel_P2_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804590	Flow cytometry workspace	Panel_P13_Run_5-regated.804590.wsp	Panel_P13_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804589	Flow cytometry workspace	Panel_P9-P10_Run_5-regated.804589.wsp	Panel_P9-P10_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804588	Flow cytometry workspace	Panel P1 Run 5b.804588.wsp	Panel P1 Run 5b.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804587	Flow cytometry workspace	Yr2 Run 5 Panel L5.804587.wsp	Yr2 Run 5 Panel L5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804586	Flow cytometry workspace	Panel_L4_Run_5-regated.804586.wsp	Panel_L4_Run_5-regated.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804585	Flow cytometry workspace	Panel_L3_Run_5.804585.wsp	Panel_L3_Run_5.wsp
SUB120458	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689546			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804584	Flow cytometry workspace	Panel_L2_Run_5-regated.804584.wsp	Panel_L2_Run_5-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689547			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004697		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689548			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005437		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689549			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005518		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120459	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689550			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004670		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689551			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004597		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689552			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003919		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689553			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005267		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120460	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689554			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003666		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752389			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005241		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752390			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003776		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120461	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752391			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004243		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689555			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689556			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005401		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689557			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004752		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120462	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		26	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689558			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004987		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689559			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004596		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689560			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004419		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689561			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004453		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120466	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		68	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689562			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004517		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689563			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689564			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005089		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689565			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004897		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804592	Flow cytometry workspace	Panel_L1_Run_6.804592.wsp	Panel_L1_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804600	Flow cytometry workspace	Panel_P2_Run_6-regated.804600.wsp	Panel_P2_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804599	Flow cytometry workspace	Panel_P13_Run_6-regated.804599.wsp	Panel_P13_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804598	Flow cytometry workspace	Panel P9-P10 Run 6.804598.wsp	Panel P9-P10 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804597	Flow cytometry workspace	Panel P1 Run 6.804597.wsp	Panel P1 Run 6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804596	Flow cytometry workspace	Yr2 Run 6 Panel L5.804596.wsp	Yr2 Run 6 Panel L5.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804595	Flow cytometry workspace	Panel_L4_Run_6-regated.804595.wsp	Panel_L4_Run_6-regated.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804594	Flow cytometry workspace	Panel_L3_Run_6.804594.wsp	Panel_L3_Run_6.wsp
SUB120467	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689566			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004239		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804593	Flow cytometry workspace	Panel_L2_Run_6-regated.804593.wsp	Panel_L2_Run_6-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689567			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005473		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689568			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004976		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689569			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003803		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120469	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		24	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689570			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004936		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689571			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005652		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689572			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004816		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689573			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005062		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120470	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		25	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752392			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003871		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752393			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004310		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752395			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003754		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120471	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at enrollment		27	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752396			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004218		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689575			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004118		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689576			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003849		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120472	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at enrollment		23	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689577			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003861		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689579			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005377		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689580			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005359		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689581			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003712		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120473	Homo sapiens	White		Hispanic or Latino		Male	Age at enrollment		30	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689582			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005031		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689583			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004279		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689584			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005160		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689585			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004183		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120474	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		22	Years	Younger adult	ARM2358	Young adults 21-30 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689586			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004296		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752401			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003834		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752402			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005685		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752403			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005547		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120478	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		78	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752405			PBMC		35	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003962		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689587			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003788		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689588			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004472		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804601	Flow cytometry workspace	Panel_L1_Run_7-regated.804601.wsp	Panel_L1_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804609	Flow cytometry workspace	Panel_P2_Run_7-regated.804609.wsp	Panel_P2_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804608	Flow cytometry workspace	Panel_P13_Run_7-regated.804608.wsp	Panel_P13_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804607	Flow cytometry workspace	Panel_P9-P10_Run_7-regated.804607.wsp	Panel_P9-P10_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804606	Flow cytometry workspace	Panel P1 Run 7.804606.wsp	Panel P1 Run 7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804605	Flow cytometry workspace	Yr2 Run 7 Panel L5.804605.wsp	Yr2 Run 7 Panel L5.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804604	Flow cytometry workspace	Panel_L4_Run_7-regated.804604.wsp	Panel_L4_Run_7-regated.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804603	Flow cytometry workspace	Panel_L3_Run_7.804603.wsp	Panel_L3_Run_7.wsp
SUB120479	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		74	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752408			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004034		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804602	Flow cytometry workspace	Panel L2 Run 7.804602.wsp	Panel L2 Run 7.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689591			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004572		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689592			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003802		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689593			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005056		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120480	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		82	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689594			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005495		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689595			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005189		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689596			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004699		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689597			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1005250		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120481	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689598			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004825		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752409			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004035		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752410			PBMC		2	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003678		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752411			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004144		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120482	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		73	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752412			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004262		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689599			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003948		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689600			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004982		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689601			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004161		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120483	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		73	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689602			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004532		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689603			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004109		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689604			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005003		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689605			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004767		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120484	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at enrollment		76	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689606			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1005344		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689607			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003984		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689608			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1003886		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689609			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004329		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804610	Flow cytometry workspace	Panel_L1_Run_8-regated.804610.wsp	Panel_L1_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804618	Flow cytometry workspace	Panel_P2_Run_8-regated.804618.wsp	Panel_P2_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804617	Flow cytometry workspace	Panel_P13_Run_8-regated.804617.wsp	Panel_P13_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804616	Flow cytometry workspace	Panel_P9-P10_Run_8-regated.804616.wsp	Panel_P9-P10_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804615	Flow cytometry workspace	Panel P1 Run 8.804615.wsp	Panel P1 Run 8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804614	Flow cytometry workspace	Yr2 Run 8 Panel L5.804614.wsp	Yr2 Run 8 Panel L5.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804613	Flow cytometry workspace	Panel_L4_Run_8-regated.804613.wsp	Panel_L4_Run_8-regated.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804612	Flow cytometry workspace	Panel_L3_Run_8.804612.wsp	Panel_L3_Run_8.wsp
SUB120485	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at enrollment		66	Years	Older adult, not-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689610			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1004020		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804611	Flow cytometry workspace	Panel L2 Run 8.804611.wsp	Panel L2 Run 8.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752416			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1005657		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752417			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004126		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752418			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1003681		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120486	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		90	Years	Older adult, frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS752419			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003718		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689611			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1004215		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689612			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1004967		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120487	Homo sapiens	White		Not Hispanic or Latino		Male	Age at enrollment		71	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689613			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004321		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689615			PBMC		0	Days	Time of initial vaccine administration			PV3222	Pre Visit	EXP13917	ES1003904		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689616			PBMC		4	Days	Time of initial vaccine administration			PV3223	Early Visit	EXP13917	ES1005069		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689617			PBMC		7	Days	Time of initial vaccine administration			PV3224	Middle Visit	EXP13917	ES1004331		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804547	Flow cytometry workspace	Panel_L1_Run_9-regated.804547.wsp	Panel_L1_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804548	Flow cytometry workspace	Panel_L2_Run_9-regated.804548.wsp	Panel_L2_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804549	Flow cytometry workspace	Panel_L3_Run_9.804549.wsp	Panel_L3_Run_9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804550	Flow cytometry workspace	Panel_L4_Run_9-regated.804550.wsp	Panel_L4_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804551	Flow cytometry workspace	Yr2 Run 9 Panel L5.804551.wsp	Yr2 Run 9 Panel L5.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804552	Flow cytometry workspace	Panel P1 Run 9.804552.wsp	Panel P1 Run 9.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804553	Flow cytometry workspace	Panel_P9-P10_Run_9-regated.804553.wsp	Panel_P9-P10_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804554	Flow cytometry workspace	Panel_P13_Run_9-regated.804554.wsp	Panel_P13_Run_9-regated.wsp
SUB120488	Homo sapiens	White		Not Hispanic or Latino		Female	Age at enrollment		87	Years	Older adult, pre-frail	ARM2359	Older adults >= 65 years old	SDY404	Immunologic and genomic signatures of influenza vaccine response - 2011 (see companion studies SDY63, SDY400, SDY520)	BS689618			PBMC		28	Days	Time of initial vaccine administration			PV3225	Late Visit	EXP13917	ES1003728		FCM	TR_NoTreatment	ESR15673, ESR15674, ESR15678, ESR15706, ESR15720, ESR15721, ESR15722, ESR15723, ESR15724, ESR15725, ESR16851	RA_Flu_FCM_Y2_Live-Dead Fixable Red_NA, RA_Flu_FCM_Y2_CD4_3262932, RA_Flu_FCM_Y2_CD8_2104653, RA_Flu_FCM_Y2_CD16_3235531, RA_Flu_FCM_Y2_CD56_3039996, RA_Flu_FCM_Y2_Granzyme B_3259736, RA_Flu_FCM_Y2_TNFa_3303891, RA_Flu_FCM_Y2_IFN-g_NA, RA_Flu_FCM_Y2_IL-17_3207775, RA_Flu_FCM_Y2_CD3_2326874, P9	PETxR, PCP5.5, APC-H7, APC, PC7, FITC, PE, AF-700, V450, V500, 	804555	Flow cytometry workspace	Panel P2 Run 9.804555.wsp	Panel P2 Run 9.wsp
